Short description
Applied Immune Technologies is focused on developing therapeutic molecules for cancer, viral, and autoimmune diseases.
Description
Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications in pathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Last funding
Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Haifa, Hefa, Israel, Asia
Founded on
January 1, 2006
Closed on
January 27, 2016
Exited on
January 27, 2016
Non-profit?
No
Acquired?
No
Employees count
101-250
Investors
No Way
Sign in for full access
Founders
Mira Kamar, Yoram Reiter